• Home
  • Stocks
  • Sun Pharma Advanced Research Company Ltd.

Sun Pharma Advanced Research Company Ltd.

View in App
333.65 -17.55 ▼-5.0%

19 April 2024, 04:01:00 PM
Volume: 8,807

Company Profile

View details >>
Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.sparc.life
Market Cap 10,827.66 Cr.
Enterprise Value(EV) 10,612.98 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) -11.20 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2023-12
Industry PE 40.73 Trailing Twelve Months Ending 2023-12
Book Value / Share 7.15 Trailing Twelve Months Ending 2023-12
Price to Book Value 46.66 Calculated using Price: 333.65
Dividend Yield 0.00 Period Ending 2023-03
No. of Shares Subscribed 32.45 Cr. 324,521,588 Shares
FaceValue 1
About Sun Pharma Advanced Research Company Ltd.
The company is engaged in the pharmaceutical research and development. The company's core focus is innovation and new product development for global markets. SPARC undertakes projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS).

Sun Pharma Advanced Research Company Ltd. Delivery

View details >>
Delivered Qty
Traded Qty

Sun Pharma Advanced Research Company Ltd. Performance

View details >>
1 Day
-5.00%
1 Week
-22.60%
1 Month
-7.79%
3 Month
-11.91%
6 Month
+38.96%
1 Year
+71.01%
2 Year
+18.99%
5 Year
+85.77%
10 Year
+123.06%

Sun Pharma Advanced Research Company Ltd. Fundamental Ratios

View details >>
9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) -33.17 -109.16 -127.4 -156.84 -74.72 -225.08 0 0 -143.72
Return on Capital Employed (%) -31.74 -71.37 -94.66 -113.05 -59.95 -178.95 -254.1 -225.57 -69.44
Return on Assets (%) -23.65 -44.68 -53.72 -66.85 -40.89 -93.11 -60.18 -79.8 -40.1

Sun Pharma Advanced Research Company Ltd. Balance Sheet

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 100 32 158 185 296 -19 -168 31 513 332
Non Curr. Liab. 10 10 10 12 7 56 165 77 138 123
Curr. Liab. 37 125 108 116 95 235 233 171 179 213
Minority Int.
Equity & Liab. 147 167 277 313 398 273 230 280 830 667
Non Curr. Assets 83 99 118 138 141 205 167 209 375 225
Curr. Assets 63 67 158 175 257 67 60 71 455 443
Misc. Exp. not W/O 0 1
Total Assets 147 167 277 313 398 273 230 280 830 667

Sun Pharma Advanced Research Company Ltd. Profit and Loss

View details >>
Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 156 161 181 78 183 77 253 137 239 107
Other Income 3 3 14 5 14 10 5 7 11 36
Total Income 159 164 195 83 196 87 258 144 250 142
Total Expenditure -191 -224 -304 -321 -334 -387 -388 -324 -453 -493
PBIDT -32 -60 -109 -238 -138 -300 -130 -180 -203 -350
Interest 0 -2 -2 0 0 -3 -11 -13 -8 -1
Depreciation -7 -8 -8 -8 -8 -9 -11 -10 -12 -12
Taxation
Exceptional Items 49
PAT -40 -70 -119 -197 -145 -312 -151 -203 -223 -363
Adjusted EPS -2 -3 -5 -8 -6 -12 -6 -7 -7 -11

Sun Pharma Advanced Research Company Ltd. Cash Flow

View details >>
Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 37 -41 -44 -128 -183 -172 -211 -152 -208 -69
Cash Fr. Inv. 44 53 -13 -7 -105 -102 155 2 -29 -548
Cash Fr. Finan. -81 -1 51 194 224 274 55 159 229 617
Net Change 0 11 -7 60 -63 0 9 -8 -1
Cash & Cash Eqvt 0 11 4 64 0 0 0 9 1 1

Sun Pharma Advanced Research Company Ltd. Shareholding Pattern

View details >>
9 Qtrs 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%) 2024-03 (%)
Promoter 69.09 69.09 69.09 68.22 65.67 65.67 65.67 65.67 65.67
Public 30.91 30.91 30.91 31.78 34.33 34.33 34.33 34.33 34.33
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 2.18 2.18 1.65 1.02 2.78 2.78 2.78 2.78 2.78
No. of Shareholders (in Lacs)

Sun Pharma Advanced Research Company Ltd. Announcements

View details >>
Thu, 18 Apr 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Transcript of the Investors call on Vodobatinib Parkinsons Disease program held on April 15 2024
Wed, 17 Apr 2024
Audio Playback Of The Investor Call For Vodobatinib Parkinson''s Disease Program
As attached
Fri, 12 Apr 2024
Certificate Under Regulation 40 (9) Of The SEBI (LODR) Regulations 2015
As attached

Sun Pharma Advanced Research Company Ltd. Technical Scans

View details >>
Fri, 19 Apr 2024
Opening at High Opening at High
Opening at Low Opening at Low
Opening at High for 3 days Opening at High for 3 days
Closing Below Previous Low Closing Below Previous Low
Closing Below Previous Low for 3 days Closing Below Previous Low for 3 days

Sun Pharma Advanced Research Company Ltd. Related Stocks

View details >>
  • SALES
Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 365,310.75 1,525.00 +0.5%
Cipla Ltd. 108,622.88 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. 99,134.26 5,942.65 -0.3%
Divi's Laboratories Ltd. 97,408.39 3,673.85 -1.2%
Mankind Pharma Ltd. 93,565.44 2,362.00 -1.5%
Zydus Lifesciences Ltd. 92,794.90 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. 88,715.85 6,152.25 +1.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.02 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-12 29.29 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 18.96 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 70.43 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-12 54.18 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 31.20 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 112.40 6,152.25 +1.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.85 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-12 4.19 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.69 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-12 7.47 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-12 10.53 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.92 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 13.14 6,152.25 +1.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 0.02 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,152.25 +1.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,152.25 +1.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 12.85 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,152.25 +1.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,152.25 +1.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,525.00 +0.5%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,345.35 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,942.65 -0.3%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,673.85 -1.2%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 2,362.00 -1.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 925.95 -1.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,152.25 +1.4%

Sun Pharma Advanced Research Company Ltd. FAQ's

What is Sun Pharma Adv. Res share price?
Can I buy Sun Pharma Adv. Res shares now?
What is the Market Cap of Sun Pharma Adv. Res?
What are the key metrics to analyse Sun Pharma Adv. Res?
What is the 52 Week High and Low of Sun Pharma Adv. Res?
What is the trend of Sun Pharma Adv. Res share price?